AIM: To appraise the correlation of mutation and methylation of hMSH1 with microsatellite instability (MSI) in gastric cancers. METHODS: Mutation of hMLH1 was detected by Two-dimensional electrophoresis (Two-D) and DNA sequencing; Methylation of hMLH1 promoter was measured with methylation-specific PCR; MSI was analyzed by PCR-based methods. RESULTS: Sixty-eight cases of sporadic gastric carcinoma were studied for mutation and methylation of hMLH1 promoter and MSI. Three mutations were found, two of them were caused by a single bp substitution and one was caused by a 2 bp substitution, which displayed similar Two-D band pattern. Methylation of hMLH1 promoter was detected in 11(16.2 %) gastric cancer. By using five MSI markers, MSI in at least one locus was detected in 17/68(25 %) of the tumors analyzed. Three hMLH1 mutations were all detected in MSI-H (>=2 loci, n=8), but no mutation was found in MSI-L (only one locus, n=9) or MSS (tumor lacking MSI or stable, n=51). Methylation frequency of hMLH1 in MSI-H (87.5 %, 7/8) was significantly higher than that in MSI-L (11.1 %, 1/9) or MSS (5.9 %, 3/51) (P<0.01-0.001), but no difference was found between MSI-L and MSS (P>0.05). CONCLUSION: Both mutation and methylation of hMLH1 are involved in the MSI pathway but not related to the LOH pathway in gastric carcinogenesis.
AIM: To appraise the correlation of mutation and methylation of hMSH1 with microsatellite instability (MSI) in gastric cancers. METHODS: Mutation of hMLH1 was detected by Two-dimensional electrophoresis (Two-D) and DNA sequencing; Methylation of hMLH1 promoter was measured with methylation-specific PCR; MSI was analyzed by PCR-based methods. RESULTS: Sixty-eight cases of sporadic gastric carcinoma were studied for mutation and methylation of hMLH1 promoter and MSI. Three mutations were found, two of them were caused by a single bp substitution and one was caused by a 2 bp substitution, which displayed similar Two-D band pattern. Methylation of hMLH1 promoter was detected in 11(16.2 %) gastric cancer. By using five MSI markers, MSI in at least one locus was detected in 17/68(25 %) of the tumors analyzed. Three hMLH1 mutations were all detected in MSI-H (>=2 loci, n=8), but no mutation was found in MSI-L (only one locus, n=9) or MSS (tumor lacking MSI or stable, n=51). Methylation frequency of hMLH1 in MSI-H (87.5 %, 7/8) was significantly higher than that in MSI-L (11.1 %, 1/9) or MSS (5.9 %, 3/51) (P<0.01-0.001), but no difference was found between MSI-L and MSS (P>0.05). CONCLUSION: Both mutation and methylation of hMLH1 are involved in the MSI pathway but not related to the LOH pathway in gastric carcinogenesis.
Authors: M Pinto; C Oliveira; J C Machado; L Cirnes; J Tavares; F Carneiro; R Hamelin; R Hofstra; R Seruca; M Sobrinho-Simões Journal: Lab Invest Date: 2000-12 Impact factor: 5.662
Authors: Siobhan S Wahlberg; James Schmeits; George Thomas; Massimo Loda; Judy Garber; Sapna Syngal; Richard D Kolodner; Edward Fox Journal: Cancer Res Date: 2002-06-15 Impact factor: 12.701
Authors: M Rugge; G Bersani; R Bertorelle; G Pennelli; V M Russo; F Farinati; D Bartolini; M Cassaro; V Alvisi Journal: J Clin Pathol Date: 2005-08 Impact factor: 3.411
Authors: S Komatsu; D Ichikawa; S Hirajima; H Nagata; Y Nishimura; T Kawaguchi; M Miyamae; W Okajima; T Ohashi; H Konishi; A Shiozaki; H Fujiwara; K Okamoto; H Tsuda; I Imoto; J Inazawa; E Otsuji Journal: Br J Cancer Date: 2014-10-16 Impact factor: 7.640
Authors: Y Nishimura; S Komatsu; D Ichikawa; H Nagata; S Hirajima; H Takeshita; T Kawaguchi; T Arita; H Konishi; K Kashimoto; A Shiozaki; H Fujiwara; K Okamoto; H Tsuda; E Otsuji Journal: Br J Cancer Date: 2013-02-19 Impact factor: 7.640